Impact of Tacrolimus and Mycophenolate Mofetil Combination on Cardiovascular Risk Profile after Kidney Transplantation-Reference-Cited by-同舟云学术

Impact of Tacrolimus and Mycophenolate Mofetil Combination on Cardiovascular Risk Profile after Kidney Transplantation

Published:2006-11-27 Issue:12 suppl 3 Volume:17 Page:S296-S303
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Morales Jose María,Domínguez-Gil Beatriz

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference33 articles.

1. Late renal allograft failure between 1990 and 1998 in Spain: A changing scenario1

2. Kasiske BL: Cardiovascular Risk Factors Associated with Immunosuppression in Renal Transplantation. Available at: http//www.scientific_frontiers.com/6010/slides/index.asp. Accessed June 2004

3. Strategies to Improve Long-Term Outcomes after Renal Transplantation

4. Immunosuppression: Evolution in Practice and Trends, 1994-2004

5. A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years1

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex-Specific Responses to Tacrolimus and Mycophenolate Mofetil in Spontaneously Hypertensive Rats;Future Pharmacology;2023-11-10

2. Therapy in the Course of Kidney Graft Rejection—Implications for the Cardiovascular System—A Systematic Review;Life;2023-06-27

3. Hypertension in kidney transplant recipients;World Journal of Transplantation;2022-08-18

4. New Approaches to Cardiovascular Disease and its Management in Kidney Transplant Recipients;Transplantation;2021-11-29

5. Role of hypertension in kidney transplant recipients;Journal of Human Hypertension;2021-05-04